Sign Up

BLFE

COM:BIOLIFESCIENCES

BioLife Sciences

  • Stock

USD

Market Cap

118

Beta: -

Volume Today

50

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Nov '19
Nov '20
Nov '21
Nov '22
net income
-1.13K
-
-1.27M
111,693.47%
depreciation and amortization
deferred income tax
stock based compensation
change in working capital
1.15K
-
379.11K
32,837.62%
accounts receivables
inventory
18
-
accounts payables
1.15K
-
414.97K
35,952.74%
other working capital
-35.87K
-
other non cash items
-0.00
-
4.32K
4,340,746,247,987,902,464%
net cash provided by operating activities
17.00
-
-884.31K
5,201,911.76%
investments in property plant and equipment
-961
-
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-961
-
debt repayment
-875.80K
-
common stock issued
common stock repurchased
dividends paid
other financing activites
net cash used provided by financing activities
875.80K
-
effect of forex changes on cash
44.19K
-
net change in cash
-1.30K
-
34.72K
2,764.85%
cash at beginning of period
1.32K
-
17
98.71%
34.74K
204,252.94%
cash at end of period
17
-
34.74K
204,252.94%
34.74K
0%
operating cash flow
17.00
-
-884.31K
5,201,911.76%
capital expenditure
-961
-
free cash flow
17.00
-
-885.27K
5,207,564.71%

All numbers in USD (except ratios and percentages)